000			01635 a2200313 4500
008			040419s xx 000 0 eng
022			_a1522-3221;
050			_aAC1.S5
082			_a050
100			_aConcar, David,
245		2	_aA Bitter Pill. _cDavid Concar.
260			_bAmnesty Now, _c2003.
440			_aSIRS Enduring Issues 2004. _nArticle 71, _pGlobal Issues, _x1522-3221;
500			_aArticles Contained in SIRS Enduring Issues 2004.
500			_aOriginally Published: A Bitter Pill, Summer 2003; pp. 10+.
520			_a"Shoe and clothing companies were among the first to seek out the cheap labor, tax breaks, and looser regulations of developing countries in the recent wave of globalization. Pharmaceutical companies discovered that they, too, could save money and time by moving the costliest part of their business--clinical trials--overseas." (AMNESTY NOW) The author examines the practices of pharmaceutical companies and suggests that the "side effects of globalizing human experimentation may include questionable ethics, preventable deaths and violations of international agreements."
599			_aRecords created from non-MARC resource.
650			_aClinical trials
650			_aDrugs _xTesting
610			_aEli Lilly and Company
650			_aGlobalization
650			_aHuman experimentation in medicine
650			_aMedical care _zDeveloping countries
610			_aPfizer Inc.
650			_aPharmaceutical ethics
650			_aPharmaceutical industry
710			_aProQuest Information and Learning Company _tSIRS Enduring Issues 2004, _pGlobal Issues. _x1522-3221;
942			_c UKN
999			_c35356 _d35356